Asthma Clinical Trial
Official title:
Effects of an Intra-hospital Exercise Program for Children With Asthma and Respiratory Symptoms
| NCT number | NCT02693301 |
| Other study ID # | R-0031/14A |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 2016 |
| Est. completion date | October 2018 |
| Verified date | February 2020 |
| Source | Universidad Europea de Madrid |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
exercise program in the pulmonary function and cardiorespiratory fitness in children with asthma and respiratory symptoms
| Status | Completed |
| Enrollment | 53 |
| Est. completion date | October 2018 |
| Est. primary completion date | May 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 7 Years to 17 Years |
| Eligibility |
Inclusion Criteria: - Diagnosed with Asthma following the GEMA 2009 criteria (Spanish Guide for Asthma Management) at least 6 months prior to the study. - Complete successfully both Cardiorespiratory and Functional Tests. Exclusion Criteria: - Diagnosed with other chronic respiratory disease or condition - Diagnosed with any chronic disease including cardiovascular diseases. - Reduced mobility - Uncooperative - Poor adherence to medication |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Hospital Infantil Universitario Niño Jesus | Madrid |
| Lead Sponsor | Collaborator |
|---|---|
| Universidad Europea de Madrid |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in Pulmonary Function (Lung Function) | Change from baseline to 2 months, and 3 months | Baseline, 2 months, and 3 months | |
| Primary | Change in Cardiorespiratory Fitness | Change from baseline to 2 months, and 3 months using Cardiorespiratory Test | Baseline, 2 months, and 3 months | |
| Primary | Change in Muscle Strength | Change from baseline to 2 months, and 3 months using one repetition maximum test | Baseline, 2 months, and 3 months | |
| Primary | Change in Quality of life and anxiety status | Change from baseline to 2 months, and 3 months using the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) (Guyatt GH, 1997) | Baseline, 2 months, and 3 months | |
| Primary | Change in anxiety | Change from baseline to 2 months, and 3 months using STAIC (State-Trait Anxiety Inventory for Children) | Baseline, 2 months, and 3 months | |
| Primary | Change in Body Mass Index (BMI) | Change from baseline to 2 months, and 3 months using height and weight. | Baseline, 2 months, and 3 months | |
| Primary | Change in Waist-to-Height index | Change from baseline to 2 months, and 3 months using height and waist. | Baseline, 2 months, and 3 months | |
| Primary | Change in anthropometric outcomes | Change from baseline to 2 months, and 3 months using skinfolds, and circumferences. | Baseline, 2 months, and 3 months | |
| Primary | Change in Body Composition | Change from baseline to 2 months, and 3 months using Bioimpedance. | Baseline, 2 months, and 3 months | |
| Primary | Changes in Physical Activity using questionnaires | Change from baseline to 2 months, and 3 months using Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A) | Baseline, 2 months, and 3 months | |
| Primary | Change in Agility walking | Change from baseline to 2 months, and 3 months using Test of Up and Go | Baseline, 2 months, and 3 months | |
| Primary | Change in Agility stairs. | Change from baseline to 2 months, and 3 months using Test of Up and Down Stairs (TUDS) | Baseline, 2 months, and 3 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|